Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark L Schultz

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Nature Communications|September 12, 2018
Coordinate regulation of mutant NPC1 degradation by selective ER autophagy and MARCH6-dependent ERADMark L Schultz, Kelsey L Krus, Susmita Kaushik, et al.
Journal of Proteome Research|April 30, 2024
Endogenous Protein-Protein Interaction Network of the NPC Cholesterol Transporter 1 in the Cerebral CortexRoshan Javanshad, Thu T A Nguyen, Ruth D Azaria, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|August 26, 2023
Apolipoprotein-mimetic nanodiscs reduce lipid accumulation and improve liver function in acid sphingomyelinase deficiencyTroy A Halseth, Adele B Correia, Mark L Schultz, et al.
JCI Insight|October 27, 2022
Species-specific differences in NPC1 protein trafficking govern therapeutic response in Niemann-Pick type C diseaseMark L Schultz, Kylie J Schache, Ruth D Azaria, et al.
The Journal of Biological Chemistry|May 23, 2021
Enrichment of NPC1-deficient cells with the lipid LBPA stimulates autophagy, improves lysosomal function, and reduces cholesterol storageOlga Ilnytska, Kimberly Lai, Kirill Gorshkov, et al.
JCI Insight|August 29, 2024
Mutant induced neurons and humanized mice enable identification of Niemann-Pick type C1 proteostatic therapiesRuth D Azaria, Adele B Correia, Kylie J Schache, et al.
BMC Medicine|November 13, 2019
Synthetic high-density lipoprotein nanoparticles for the treatment of Niemann-Pick diseasesMark L Schultz, Maria V Fawaz, Ruth D Azaria, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Nature Communications|September 12, 2018
Coordinate regulation of mutant NPC1 degradation by selective ER autophagy and MARCH6-dependent ERADMark L Schultz, Kelsey L Krus, Susmita Kaushik, et al.
Journal of Proteome Research|April 30, 2024
Endogenous Protein-Protein Interaction Network of the NPC Cholesterol Transporter 1 in the Cerebral CortexRoshan Javanshad, Thu T A Nguyen, Ruth D Azaria, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|August 26, 2023
Apolipoprotein-mimetic nanodiscs reduce lipid accumulation and improve liver function in acid sphingomyelinase deficiencyTroy A Halseth, Adele B Correia, Mark L Schultz, et al.
JCI Insight|October 27, 2022
Species-specific differences in NPC1 protein trafficking govern therapeutic response in Niemann-Pick type C diseaseMark L Schultz, Kylie J Schache, Ruth D Azaria, et al.
The Journal of Biological Chemistry|May 23, 2021
Enrichment of NPC1-deficient cells with the lipid LBPA stimulates autophagy, improves lysosomal function, and reduces cholesterol storageOlga Ilnytska, Kimberly Lai, Kirill Gorshkov, et al.
JCI Insight|August 29, 2024
Mutant induced neurons and humanized mice enable identification of Niemann-Pick type C1 proteostatic therapiesRuth D Azaria, Adele B Correia, Kylie J Schache, et al.
BMC Medicine|November 13, 2019
Synthetic high-density lipoprotein nanoparticles for the treatment of Niemann-Pick diseasesMark L Schultz, Maria V Fawaz, Ruth D Azaria, et al.
Pageof 2